Determine the efficacy and tolerability of olanzapine for treatment of acute depression in patients with bipolar II or bipolar disorder NOS compared with lithium.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
50
Chiba University Hospital
Chiba, Japan
Change in Montgomery- Åsberg Depression Rating(MADRS)
Time frame: Baseline and 8 weeks
Change in Young Mania Rating Scale(YMARS)
Time frame: Baseline and 8 weeks
Quick Inventory of Depressive Symptomatology Japanese version(QIDS-J)
Time frame: Baseline and 8 weeks
State Trait Anxiety Inventory Form JYZ(STAI)
Time frame: Baseline and 8 weeks
Clinical Global Impression for Bipolar Disorder(CGI-BP)
Time frame: Baseline and 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.